Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis

Mårten Steen, Eva A. Norstrøm, Ann-Louise Tholander, Paula H. B. Bolton-Maggs, Andrew Mumford, John H. McVey, Edward G. D. Tuddenham, Björn Dahlbäck

Blood (2004) 103 (9): 3381–3387.

https://doi.org/10.1182/blood-2003-06-2092

Published: 2004

Journal Articles

Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized

Mårten Steen, Maria Miteva, Bruno O. Villoutreix, Tomio Yamazaki, Björn Dahlbäck

Blood (2003) 102 (4): 1316–1322.

https://doi.org/10.1182/blood-2003-01-0116

Published: 2003

Journal Articles

Gla domain–mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding

Yong-Hui Sun, Lei Shen, Björn Dahlbäck

Blood (2003) 101 (6): 2277–2284.

https://doi.org/10.1182/blood-2002-06-1691

Published: 2003

Journal Articles

Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype

Tomio Yamazaki, Gerry A. F. Nicolaes, Kristoffer W. Sørensen, Björn Dahlbäck

Blood (2002) 100 (7): 2515–2521.

https://doi.org/10.1182/blood.V100.7.2515

Published: 2002

Journal Articles

Factor V Leiden and the genetics of myocardial infarction: we need to look elsewhere

Björn Dahlbäck

Blood (2002) 100 (3): 742.

https://doi.org/10.1182/blood-2002-06-1713

Published: 2002

Journal Articles

Functional characterization of recombinant FV Hong Kong and FV Cambridge

Eva Norstrøm, Elisabeth Thorelli, Björn Dahlbäck

Blood (2002) 100 (2): 524–530.

https://doi.org/10.1182/blood-2002-02-0343

Published: 2002

Journal Articles

Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors

Tusar Kanti Giri, Tomio Yamazaki, Núria Sala, Björn Dahlbäck, Pablo Garcı́a de Frutos

Blood (2000) 96 (2): 523–531.

https://doi.org/10.1182/blood.V96.2.523

Published: 2000

Journal Articles

Protein S secretion differences of missense mutants account for phenotypic heterogeneity

Yolanda Espinosa-Parrilla, Tomio Yamazaki, Nùria Sala, Björn Dahlbäck, Pablo Garcı́a de Frutos

Blood (2000) 95 (1): 173–179.

https://doi.org/10.1182/blood.V95.1.173

Published: 2000

Journal Articles

Cleavage of Factor V at Arg 506 by Activated Protein C and the Expression of Anticoagulant Activity of Factor V

Elisabeth Thorelli, Randal J. Kaufman, Björn Dahlbäck

Blood (1999) 93 (8): 2552–2558.

https://doi.org/10.1182/blood.V93.8.2552

Published: 1999

Journal Articles

The A20210 Allele of the Prothrombin Gene Is Frequently Associated With the Factor V Arg 506 to Gln Mutation But Not With Protein S Deficiency in Thrombophilic Families

Bengt Zöller, Peter J. Svensson, Björn Dahlbäck, Andreas Hillarp

Blood (1998) 91 (6): 2210–2211.

https://doi.org/10.1182/blood.V91.6.2210

Published: 1998

Journal Articles

Genetic and Phenotypic Analysis of a Large (122-Member) Protein S–Deficient Kindred Provides an Explanation for the Familial Coexistence of Type I and Type III Plasma Phenotypes

Rachel E. Simmonds, Bengt Zöller, Helen Ireland, Elizabeth Thompson, Pablo Garcı́a de Frutos, Björn Dahlbäck, David A. Lane

Blood (1997) 89 (12): 4364–4370.

https://doi.org/10.1182/blood.V89.12.4364

Published: 1997

NARROW

Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis

Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized

Gla domain–mutated human protein C exhibiting enhanced anticoagulant activity and increased phospholipid binding

Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype

Factor V Leiden and the genetics of myocardial infarction: we need to look elsewhere

Functional characterization of recombinant FV Hong Kong and FV Cambridge

Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors

Protein S secretion differences of missense mutants account for phenotypic heterogeneity

Cleavage of Factor V at Arg 506 by Activated Protein C and the Expression of Anticoagulant Activity of Factor V

The A20210 Allele of the Prothrombin Gene Is Frequently Associated With the Factor V Arg 506 to Gln Mutation But Not With Protein S Deficiency in Thrombophilic Families

Genetic and Phenotypic Analysis of a Large (122-Member) Protein S–Deficient Kindred Provides an Explanation for the Familial Coexistence of Type I and Type III Plasma Phenotypes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only